# POLYETHYLENE GLYCOL 300

URL: https://app.greenveil.ai/ingredients/ingredient_unii_5655_g9_y8_aq
Categories: pharma
Identifier: cfr:21 CFR 349.12

> POLYETHYLENE GLYCOL 300. Route: AURICULAR (OTIC); Dosage form: DROPS; Potency: 97.43 %w/w Assessed from 15 sources.

## Safety assessment

- Chemical concern: not yet assessed
- Rationale: Route: AURICULAR (OTIC); Dosage form: DROPS; Potency: 97.43 %w/w

## Regulatory status

- US: inactive ingredient database — Route: AURICULAR (OTIC); Dosage form: DROPS; Potency: 97.43 %w/w
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: INJECTION; Maximum daily exposure: 16875 mg
- US: inactive ingredient database — Route: INTRAMUSCULAR; Dosage form: SOLUTION; Maximum daily exposure: 16920 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION; Maximum daily exposure: 2592 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: INJECTION, SOLUTION, CONCENTRATE; Potency: 44.22 %w/v
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: LIQUID; Maximum daily exposure: 5850 mg
- US: inactive ingredient database — Route: INTRAVENOUS; Dosage form: SOLUTION; Maximum daily exposure: 16920 mg
- US: inactive ingredient database — Route: OPHTHALMIC; Dosage form: OINTMENT; Potency: NA
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 1 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FILM COATED; Maximum daily exposure: 2 mg
- US: inactive ingredient database — Route: TOPICAL; Dosage form: CREAM; Maximum daily exposure: 20 mg
- US: inactive ingredient database — Route: TOPICAL; Dosage form: OINTMENT; Maximum daily exposure: 1114 mg
- US: inactive ingredient database — Route: TOPICAL; Dosage form: SOLUTION; Potency: 29.7 %w/w
- US: listed in openFDA substance — openFDA substance registry classifies this ingredient as polymer.

_Assessed by Greenveil._